The announcement of €50 million funding for new medicines by the Government has been hailed by the Irish Pharmaceutical Healthcare Association (IPHA) as a game-changer for patients with serious diseases including cancer, Parkinson’s and leukaemia.
The funding enables doctors to access over 50 medicines, with some already approved by the Health Service Executive. With further innovative treatments going through the formal assessment process, more are expected to be available in 2021.
The Government explicitly allocated funding that will cover a significant proportion of the cost of new treatments next year after the effective funding embargo for 2020.
The funding announcement was praised by the IPHA for demonstrating the Government’s commitment to medicines innovation and the resulting effects on health outcomes and economic growth.
Paul Reid, President of the IPHA:
“The €50 million in funding that the Budget sets aside for new medicines next year is a game-changer for Irish patients. It means patients will have a greater range of breakthrough treatment options available to them for serious medical conditions and faster.”
The funding decision is expected to further mobilise industry and State collaboration to increase patient access to innovative treatments and MAP will continue to track developments. Read the IPHA press release for more information.